James Moore

547 total citations
15 papers, 400 citations indexed

About

James Moore is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, James Moore has authored 15 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in James Moore's work include Colorectal Cancer Screening and Detection (7 papers), Colorectal Cancer Surgical Treatments (6 papers) and Colorectal Cancer Treatments and Studies (4 papers). James Moore is often cited by papers focused on Colorectal Cancer Screening and Detection (7 papers), Colorectal Cancer Surgical Treatments (6 papers) and Colorectal Cancer Treatments and Studies (4 papers). James Moore collaborates with scholars based in Australia, United States and Canada. James Moore's co-authors include David A. Gross, K. Renee Fister, Weiqing Gu, Lisette de Pillis, David Roder, Timothy Price, Marie‐Claude Boily, Virginia Loo, Gina Dallabetta and Catherine M Lowndes and has published in prestigious journals such as Cancer Research, AIDS and Colorectal Disease.

In The Last Decade

James Moore

15 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Moore Australia	8	193	111	92	90	75	15	400
Christopher Robertson United Kingdom	9	120 0.6×	44 0.4×	117 1.3×	30 0.3×	10 0.1×	12	490
Cynthia A. Mapua Philippines	16	129 0.7×	14 0.1×	91 1.0×	363 4.0×	44 0.6×	27	768
Su‐Jin Choi South Korea	11	100 0.5×	27 0.2×	57 0.6×	268 3.0×	26 0.3×	22	500
Xingxing Zhang China	9	78 0.4×	39 0.4×	243 2.6×	56 0.6×	10 0.1×	29	386
Marisa Langdon-Embry United States	6	88 0.5×	28 0.3×	82 0.9×	56 0.6×	9 0.1×	8	463
Rabia Ali United States	7	172 0.9×	15 0.1×	70 0.8×	49 0.5×	20 0.3×	28	349
Adam Lee United States	8	92 0.5×	36 0.3×	29 0.3×	157 1.7×	6 0.1×	32	359
Franchette van den Berkmortel Netherlands	10	296 1.5×	14 0.1×	29 0.3×	125 1.4×	11 0.1×	22	587
Christine Prosperi United States	10	72 0.4×	42 0.4×	107 1.2×	96 1.1×	15 0.2×	19	309
Gordon Hay United Kingdom	12	100 0.5×	27 0.2×	57 0.6×	170 1.9×	3 0.0×	30	524

Countries citing papers authored by James Moore

Since Specialization

Citations

This map shows the geographic impact of James Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Moore more than expected).

Fields of papers citing papers by James Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Moore. The network helps show where James Moore may publish in the future.

Co-authorship network of co-authors of James Moore

This figure shows the co-authorship network connecting the top 25 collaborators of James Moore. A scholar is included among the top collaborators of James Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Moore. James Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Kessler, Elizabeth R., Eryn Callihan, Junxiao Hu, et al.. (2023). A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma. Cancer Research Communications. 3(6). 1004–1012. 3 indexed citations

Piantadosi, Cynthia, Amanda Townsend, Christos S. Karapetis, et al.. (2021). Prognostic Differences of RAS Mutations: Results from the South Australian Metastatic Colorectal Registry. Targeted Oncology. 17(1). 35–41. 4 indexed citations

Prasanna, Thiru, Rachel Wong, Timothy Price, et al.. (2020). Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancer. Current Problems in Cancer. 45(1). 100637–100637. 13 indexed citations

Maroni, Paul, Elizabeth R. Kessler, Thomas W. Flaig, et al.. (2020). Abstract CT207: A phase II trial using grape seed extract for prostate cancer patients with non-metastatic PSA progression after local therapy. Cancer Research. 80(16_Supplement). CT207–CT207. 1 indexed citations

Moore, James, Timothy Price, Scott Carruthers, et al.. (2017). Prospective randomized trial of neoadjuvant chemotherapy during the ‘wait period’ following preoperative chemoradiotherapy for rectal cancer: results of the WAIT trial. Colorectal Disease. 19(11). 973–979. 43 indexed citations

Roder, David, Christos S. Karapetis, David A. Wattchow, et al.. (2016). Colorectal cancer treatment and survival over three decades at four major public hospitals in South Australia: trends by age and in the elderly. European Journal of Cancer Care. 25(5). 753–763. 3 indexed citations

Roder, David, Christos S. Karapetis, David A. Wattchow, et al.. (2015). Colorectal Cancer Treatment and Survival: the Experience of Major Public Hospitals in South Australia over three Decades. Asian Pacific Journal of Cancer Prevention. 16(6). 2431–2440. 35 indexed citations

Roder, David, Christos S. Karapetis, David A. Wattchow, et al.. (2015). Metastatic Colorectal Cancer Treatment and Survival: the Experience of Major Public Hospitals in South Australia Over Three Decades. Asian Pacific Journal of Cancer Prevention. 16(14). 5923–5931. 4 indexed citations

Dallabetta, Gina, Virginia Loo, Stephen Mills, et al.. (2008). Evaluation design for large-scale HIV prevention programmes: the case of Avahan, the India AIDS initiative. AIDS. 22(Suppl 5). S1–S15. 110 indexed citations

10.

Pillis, Lisette de, et al.. (2008). Mathematical Model Creation for Cancer Chemo‐Immunotherapy. Computational and Mathematical Methods in Medicine. 10(3). 165–184. 116 indexed citations

11.

Pillis, L. G. de, et al.. (2007). Seeking Bang-Bang Solutions of Mixed Immuno-Chemotherapy of Tumors. Electronic Journal of Differential Equations. 2007(171). 1–24. 30 indexed citations

12.

Moore, James. (2007). An ODE Model of Biochemotherapy Treatment for Cancer. Scholarship @ Claremont (The Claremont Colleges). 3 indexed citations

13.

Lüke, C., Bogda Koczwara, James Moore, et al.. (2005). Treatment and Survival from Colorectal Cancer: The Experience of Patients at South Australian Teaching Hospitals Between 1980 and 2002. Clinical Oncology. 17(5). 372–381. 16 indexed citations

14.

Hoffmann, D., James Moore, & David Roder. (1997). TRENDS IN SURVIVAL FROM COLONIC CANCER: THE IMPACT OF SUBSPECIALIZATION. Australian and New Zealand Journal of Surgery. 67(12). 842–845. 17 indexed citations

15.

Silverman, Stanley, James Moore, H Thompson, & M R B Keighley. (1985). Peroperative detection of patients with rectal cancer at high risk of local recurrence.. PubMed. 67(3). 164–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact